Teraflex Hondrocrem Forte, cream for acute joint pain, 50 g, Bayer
Product weight, g:
fifty
one hundred
Category
Bruises, sprains
Item weight, g
fifty
Package quantity, pcs
one
Scope of the medicinal product
Musculoskeletal system
Release form
Cream
Dosage form
Cream from light yellow with a greenish tint to yellow with a greenish tint with the smell of dimethyl sulfoxide.
Structure
Active ingredients: chondroitin sodium sulfate - 50 mg, meloxicam - 10 mg.
Excipients: dimethyl sulfoxide - 100 mg, propylene glycol - 100 mg, macrogol cetostearate - 12 mg, cetostearyl alcohol [cetyl alcohol not more than 60%, stearyl alcohol not less than 40%] - 42 mg, liquid paraffin - 100 mg, petroleum jelly - 80 mg , imidourea - 3 mg, sodium disulfite - 0.5 mg, water up to 1.00 g
Special conditions
The drug should be applied only to intact skin, avoiding contact with open wounds.
Avoid contact with the eyes and mucous membranes.
You should consult your doctor before using Teraflex® Hondrocrem Forte together with other non-steroidal anti-inflammatory drugs, and if you need to use the drug for more than 2 weeks.
Influence on the ability to drive vehicles and use mechanisms
The drug does not cause a sedative effect, psychomotor disorders and does not affect the patient's ability to engage in potentially hazardous activities that require increased attention and speed of mental and motor reactions.
Drug interactions
Cases of interaction or incompatibility with other drugs have not been described.
Pharmacodynamics
Teraflex® Chondrocrem Forte has a combined effect: it slows down the progression of osteoarthritis and osteochondrosis, has an analgesic effect, increases the range of motion of the joints (in the area of applying the cream), has an anti-inflammatory effect, and reduces joint swelling. Thanks to the optimal combination of the components of the cream, there is a mutual strengthening of their analgesic and anti-inflammatory effects.
Chondroitin sulfate is a high molecular weight mucopolysaccharide that is a natural component of cartilage tissue. Chondroitin sulfate improves phosphorus-calcium metabolism in cartilage tissue, inhibits enzymes that cause damage to cartilage tissue, inhibits degeneration (destruction) of cartilage tissue, stimulates the synthesis of glycosaminoglycans, promotes regeneration (restoration) of cartilaginous surfaces of joints, accelerates the processes of their repair, prevents the collapse of connective tissue ... This results in less pain and increased mobility in the affected joints.
Meloxicam is a non-steroidal anti-inflammatory drug that has anti-inflammatory, analgesic effects.
Meloxicam selectively inhibits cyclooxygenase 2, disrupts the metabolism of arachidonic acid, and reduces the amount of prostaglandins (mediators of pain and inflammation) in the focus of inflammation.
Meloxicam is a chondroneutral drug that does not adversely affect cartilage tissue, does not affect proteoglycan synthesis by articular cartilage chondrocytes.
Indications
The drug is recommended for use in the complex therapy of degenerative-dystrophic diseases of the musculoskeletal system: osteoarthritis, osteochondrosis of the spine
other joint diseases accompanied by pain syndrome.
Contraindications
Hypersensitivity to the components of the drug (as well as to other non-steroidal anti-inflammatory drugs), violation of the integrity of the skin in the places of intended application, children's age (up to 12 years).
Carefully
In case of impaired renal and liver function, with pronounced pathology of the gastrointestinal tract (peptic ulcer in the acute phase), with severe pathology of the blood system, old age.
Application during pregnancy and lactation
The use of the drug is contraindicated during pregnancy and lactation.
Overdose
Extremely low systemic absorption of the active components of the drug when applied externally makes an overdose almost impossible.
Side effects
Allergic skin reactions are possible (itching, redness, skin rash).
If any side effects appear, you must stop using the cream and consult a doctor.
INN / Active ingredient
Meloxicam + Chondroitin Sulfate
Dosage
1% + 5% x 50g
Indications
The drug is recommended for use in the complex therapy of degenerative-dystrophic diseases of the musculoskeletal system: osteoarthritis, osteochondrosis of the spine
other joint diseases accompanied by pain syndrome.
Contraindications
Hypersensitivity to the components of the drug (as well as to other non-steroidal anti-inflammatory drugs), violation of the integrity of the skin in the places of intended application, children's age (up to 12 years).
Carefully
In case of impaired renal and liver function, with pronounced pathology of the gastrointestinal tract (peptic ulcer in the acute phase), with severe pathology of the blood system, old age.
Specifications
Category
Bruises, sprains
Item weight, g
fifty
Package quantity, pcs
one
Scope of the medicinal product
Musculoskeletal system
Release form
Cream
Vacation conditions
Without recipe
Manufacturer country
Russia
The amount of the dosage form in the primary package
50 g
Anatomical and therapeutic characteristics
M02AX10 Other preparations
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
A type
Medicine
Drug action
Pain reliever
Dosage form
Cream for external use
Pharmaco-therapeutic group
Tissue repair stimulant + NSAIDs
Brand name
Teraflex
Expiration date in days
730
Package weight, g
65
Information on technical characteristics, delivery set, country of manufacture